Labshake search
Citations for R&D Systems :
2951 - 3000 of 4069 citations for 3 Methoxy 2 2 4 4 Tetrabde Unlabeled 50 Ug Ml In Nonane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biophysics 2021Quote: ... 1 μg/mL epidermal growth factor (EGF) (R&D Systems, #236-EG10), 10 μM ionomycin (Iono ...
-
bioRxiv - Biophysics 2020Quote: ... and 100ng/mL of recombinant interferon-γ (IFN-γ, R&D Systems) in RPMI-1640 media for 25min ...
-
bioRxiv - Biophysics 2020Quote: ... 10ng/mL recombinant tumor necrosis factor-α (TNF-α, R&D Systems), and 100ng/mL of recombinant interferon-γ (IFN-γ ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 30 ng/mL recombinant human EGF (R&D Systems, Minneapolis, MN). Cells were plated in a non-tissue culture treated 6-well plate and incubated overnight at 37°C ...
-
bioRxiv - Biochemistry 2022Quote: ... and 20 ng/ml of IL-13 (R&D Systems, #213-ILB). U937 cells were plated in complete RPMI 1640 for each condition ...
-
bioRxiv - Neuroscience 2022Quote: ... cultures were treated with IGF2 (R&D Systems; 100 ng ml−1), the PI3K/Akt inhibitor LY294002 (Sigma ...
-
bioRxiv - Immunology 2022Quote: ... IFN-γ is 9.4 – 600 pg/mL (R&D Systems, Minneapolis, USA) and IL-17 is 10.9 – 700 pg/mL (R&D Systems ...
-
bioRxiv - Immunology 2022Quote: ... the medium was supplemented with IL-12 (20ng/mL, R&D Systems). Differentiation of Treg cells was performed with TGF-β1 (2ng/mL).
-
bioRxiv - Cell Biology 2022Quote: ... human basic fibroblast growth factor (bFGF, 10 ng/ml, R&D Systems), and human fibroblast growth factor 10 (FGF10 ...
-
bioRxiv - Cancer Biology 2022Quote: ... 10 ng/mL fibroblast growth factor (R&D Systems #233-FB-025), 2% B27 (Thermo Fisher Scientific ...
-
bioRxiv - Bioengineering 2022Quote: ... or 1000 ng/mL of recombinant human IFN-γ (R&D Systems), TNF-α (R&D Systems) ...
-
bioRxiv - Developmental Biology 2022Quote: ... and 10 ng/ml Activin A (R&D Systems #338-AC-010). After 48 h ...
-
bioRxiv - Cancer Biology 2022Quote: ... or 20ng/ml recombinant TGF-β (R&D Systems, 7666-MB-005) for 5-6 d before processing and analysis by described assays.
-
bioRxiv - Neuroscience 2021Quote: ... and 100 ng/mL Shh-C24II (R&D Systems, Minneapolis, MN, USA) and 1 μM purmorphamine (Millipore ...
-
bioRxiv - Neuroscience 2020Quote: ... and 10 μL IL-34 stimulus (R&D systems, 5195-ML-CF) were incubated at 37°C for 30 minutes before 80 μL M-NFS-60 cells (103 cells/well ...
-
bioRxiv - Microbiology 2020Quote: ... or IFN-γ (200 U/ml, R&D systems 285-IF-100). 3 days post-stimulation whole cell lysates were generated.
-
bioRxiv - Molecular Biology 2020Quote: ... cells were stimulated with 50ng/ml BMP2 (R&D Systems, #355-GMP). Inhibition of the BMP signalling pathway was achieved through addition of LDN193187 dihydrochloride (Tocris ...
-
bioRxiv - Molecular Biology 2020Quote: ... siG9a cells were treated with 100ng/ml of rDKK1 (R&D Systems) or 200nM of porcupine inhibitor LGK974 (Selleck Chemicals ...
-
bioRxiv - Neuroscience 2022Quote: ... and supplemented with 20 ng/mL EGF (R&D Systems, 236-EG) and 20 ng/mL FGF2 (R&D Systems ...
-
bioRxiv - Immunology 2022Quote: ... or NKG2D neutralizing antibody (5 µg/ml, R&D Systems, MAB139-100); ILC1-like cells demonstrated cytotoxic effect on HFs with 600 cells per well ...
-
bioRxiv - Immunology 2022Quote: ... or function-blocking NKG2D (5 µg/ml, R&D Systems, MAB139-100) antibodies ...
-
bioRxiv - Pathology 2022Quote: ... MPT cells were treated with 20 ng/mL TNFα (R&D Systems) or 20 ng/mL IL-1β (R&D Systems ...
-
bioRxiv - Genomics 2019Quote: ... and 40 ng/mL recombinant basic fibroblast growth factor (R&D Systems). Cells were differentiated into neurons for 7 days using standard differentiation medium ...
-
bioRxiv - Cell Biology 2019Quote: ... 1 mM glutamine supplemented with either Bmp4 (100ng/ml; R&D Systems) or FBS (10%).
-
bioRxiv - Developmental Biology 2019Quote: ... supplemented with 10 ng/mL stem cell factor (SCF; R&D Systems), 1 ng/mL IL3 ...
-
bioRxiv - Systems Biology 2021Quote: ... 200 ng/mL of recombinant human FGF5 (R&D Systems, #237-F5), 100 ng/mL of recombinant mouse PDGFA (Novus ...
-
bioRxiv - Bioengineering 2019Quote: ... IF procedures were performed for CD31 (R&D Systems; 10 µg/mL), osteopontin (goat polyclonal ...
-
bioRxiv - Physiology 2021Quote: ... and 30ng/mL recombinant mouse M-CSF (R&D systems, Minneapolis, MN). Fresh medium was replenished every 3 days ...
-
bioRxiv - Physiology 2021Quote: ... and 30ng/mL recombinant mouse M-CSF (R&D systems, Minneapolis, MN). Fresh medium was replenished every 3 days.
-
bioRxiv - Microbiology 2020Quote: ... and IFNγ (10ng/ml; R&D Systems catalog# 285-IF-100, respectively). After 5 hours of incubation with LPS/IFNγ ...
-
bioRxiv - Immunology 2020Quote: ... HUVEC were treated with 10ng/ml TNF-α (R&D Systems, UK) for 24 hours prior to experimentation.
-
bioRxiv - Immunology 2019Quote: ... with or without 10ng/mL recombinant murine IL-23 (R&D Systems). To test the effect of VIP on ILC3 ...
-
bioRxiv - Genetics 2020Quote: ... and 100 ng/ml recombinant human SCF (R&D systems #255-SC) (referred to as X-VIVO complete medium) ...
-
bioRxiv - Developmental Biology 2021Quote: ... OPCs were treated with 50nG/mL IL1B (R&D Systems, Minneapolis, MN) or PBS for 4h ...
-
bioRxiv - Cell Biology 2021Quote: ... and the small molecules 25 ng/ml Activin A (R&D systems), 30 ng/ml Bone morphogenic protein-4 (BMP4 ...
-
bioRxiv - Systems Biology 2021Quote: ... Recombinant Mouse IGF-I/IGF-1 Protein (10ng/ml, R&D Systems), Transforming Growth Factor (TGF)β1 (10ng/ml ...
-
bioRxiv - Cancer Biology 2020Quote: ... 10 ng/mL NRG1-β1/HRG-β1 (396-HB, R&D Systems), 100 IU/mL penicillin/streptomycin and 1 μg/mL amphotericin B ...
-
bioRxiv - Developmental Biology 2020Quote: ... and 100 ng/mL recombinant human Activin A protein (R&D Systems). For neurectoderm-directed differentiation ...
-
bioRxiv - Developmental Biology 2020Quote: ... 100ng/mL Activin A (Cat #: 338-AC, R&D Systems, Minneapolis, MN), 20ng/mL FGF2 (Cat # ...
-
bioRxiv - Developmental Biology 2021Quote: ... and vascular endothelial growth factor (VEGF, 10 ng/ml, R&D Systems). On day 5 EBs were dissociated ...
-
bioRxiv - Biophysics 2021Quote: ... 250 μl/well of 0.05 mg/ml fibronectin (R&D Systems, US) solution in MilliQ were added to the now highly reactive surface and incubated at room temp for 2 hours ...
-
bioRxiv - Physiology 2021Quote: ... 1X REGMTM SingleQuotsTM kit and 10 ng/mL rhEGF (R&D system) and was then changed every 2 days ...
-
bioRxiv - Immunology 2021Quote: ... IL-6 (1000 U/mL; R&D Systems Cat# 206–1 L), and PGE2 (2 μM ...
-
bioRxiv - Immunology 2021Quote: ... or M-CSF (25 ng/mL, 216-MC-025, R&D Systems) in the presence or absence of purified β-glucan from Candida albicans (10 μg/mL unless otherwise stated ...
-
bioRxiv - Immunology 2021Quote: ... and IL-1β (10 ng/mL; R&D Systems; 201-LB-005). Compound or DMSO vehicle control was added on day 0 ...
-
bioRxiv - Developmental Biology 2020Quote: ... and either 500 ng/ml mouse RSPO1 (R&D systems, 3474-RS) or 10% RSPO1-conditioned medium ...
-
bioRxiv - Cell Biology 2021Quote: ... or Ephrin A5 (1 µg/ml, R&D Systems, Cat. 374-EA) for 1 ...
-
bioRxiv - Cell Biology 2020Quote: ... and 10 ng/ml TGF-β3 (R&D Systems; Minneapolis, MN, USA), the cells were plated in V-bottom polypropylene 96 well plates (Phenix #MPG-651201 ...
-
bioRxiv - Developmental Biology 2022Quote: ... and 25 ng ml-1 FGF4 (R&D Systems 7486-F4-025) for three days (with Y-27632 added for the first 24 hours only) ...
-
bioRxiv - Cell Biology 2022Quote: ... 10 ng/mL human recombinant activin B (R&D Systems, Minneapolis, MN), 0.1 nmol/L exendin-4 (Sigma) ...